Form4insider filings, from the source

SEC Form 4 · accession 0000899243-15-010065

IDERA PHARMACEUTICALS, INC. · IDRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Youssef El Zein
Director · 10% Owner
Pillar Pharmaceuticals I LP
Director · 10% Owner
Pillar Invest Corp
Director · 10% Owner
Pillar Pharmaceuticals II, L.P.
Director · 10% Owner
Pillar Pharmaceuticals IV, L.P.
Director · 10% Owner
Period of report
Dec 15, 2015
Accepted (ET)
Dec 17, 2015 · 6:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F4Dec 15, 2015S$077,586$0.00D0ISee Footnotes
Common StockF2,F4Dec 15, 2015S$077,586$0.00D0ISee Footnotes
Common StockF3,F4Dec 15, 2015S$077,587$0.00D0ISee Footnotes
Common StockF5,F4Dec 17, 2015X232,759$0.00A0ISee Footnotes

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
WarrantsF4,F5$0.70Dec 17, 2015X232,759DNov 9, 2012Nov 9, 2017Common Stock232,7595,034,061I

Explanation of responses